ketoconazole has been researched along with Carcinoma, Thymic in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| San Filippo, J | 1 |
| Palestine, RF | 1 |
| Su, WP | 1 |
| Liesegang, TJ | 1 |
1 review available for ketoconazole and Carcinoma, Thymic
| Article | Year |
|---|---|
Chronic mucocutaneous candidiasis associated with malignant thymoma and systemic lupus erythematosus with hypergammaglobulinemia: a case report and literature review.
Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Humans; Hypergammaglobulinemia; Itraco | 2006 |
1 other study available for ketoconazole and Carcinoma, Thymic
| Article | Year |
|---|---|
Late-onset chronic mucocutaneous and ocular candidiasis and malignant thymoma.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Conjunctival Diseases; Humans; Imidazoles; Ketocona | 1983 |